Earl Collier is executive vice president of Genzyme Corporation. He is responsible for managing Genzyme’s oncology and cardiovascular businesses. He joined Genzyme full time in 1997, but his relationship with the company dates to 1990, when he began working with Genzyme as an outside lawyer. At Genzyme he was also president of Genzyme Biosurgery and its predecessor, Genzyme Surgical Products.

Mr. Collier has more than 20 years of experience in healthcare. He was president of Vitas Healthcare Corp from 1991 to 1995. Vitas is the largest provider of hospice services in the U.S. Between 1981 and 1991, Mr. Collier was a partner at Hogan & Hartson law firm in Washington, D.C. He served as deputy administrator for the Health Care Financing Administration (HCFA) in Baltimore, MD, during the Carter Administration. From 1977 to 1979, Mr. Collier was deputy administrator of the New York State offices of Health Systems Management. Mr. Collier was an associate at Covington and Burlington law firm in Washington, D.C., from 1974 to 1977. He began his legal career in Washington as a clerk for the U.S. Court of Appeals.

Mr. Collier sits on the board of The Covalent Group, Inc. and Excigen Inc. He earned a B.A. at Yale University and a J.D. at the University of Virginia Law School.